INBX vs REGN: Which Stock is Better?

Side-by-side comparison of Inhibrx Biosciences Inc and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

INBX

Inhibrx Biosciences Inc

$88.23

REGN

Regeneron Pharmaceuticals Inc

$750.57

Key Metrics Comparison

MetricINBXREGNWinner
Market Cap$1.21B$79.35BREGN
P/E RatioN/A18.08REGN
EPS (TTM)$N/A$41.51REGN
Revenue Growth-1.0%0.0%REGN
Gross Margin-8594.5%44.6%REGN

Analyze INBX

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is INBX or REGN a better investment?

Comparing INBX and REGN: Inhibrx Biosciences Inc has a market cap of $1.21B while Regeneron Pharmaceuticals Inc has $79.35B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between INBX and REGN?

INBX (Inhibrx Biosciences Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: INBX or REGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: INBX or REGN?

REGN has higher revenue growth at 0.0% vs -1.0% for INBX.

Which company is more profitable: INBX or REGN?

Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to -8594.5% for INBX.

Which is the larger company: INBX or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $79.35B compared to $1.21B for INBX.

Should I buy INBX or REGN in 2026?

Both INBX and REGN have investment merit. INBX trades at $88.23 while REGN trades at $750.57. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between INBX and REGN stock?

Key differences: Market Cap ($1.21B vs $79.35B), P/E Ratio (N/A vs 18.1x), Revenue Growth (-1.0% vs 0.0%), Gross Margin (-8594.5% vs 44.6%).

Popular Stock Comparisons